AI assistant
Sending…
RESMED INC — Director's Dealing 2011
Aug 18, 2011
30071_dirs_2011-08-18_ad092ca6-0c00-4e69-b83a-dfee0012660f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2011-08-16
Reporting Person: FARRELL PETER C (Director, CEO and Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-08-16 | ResMed Common Stock | A | 28571 | — | Acquired | 729579 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 3317 | Indirect |
| ResMed Common Stock | 21391 | Indirect |
| Resmed Common Stock | 200000 | Indirect |
Footnotes
F1: Represents Performance-based Restricted Stock Units initially granted on November 11, 2010, but earned as of August 16, 2011, based on corporate performance. The RSUs are subject to a vesting requirement of 25% per year, with the first vesting on November 11, 2011.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29